The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2026

Filed:

Oct. 18, 2021
Applicant:

The Cleveland Clinic Foundation, Cleveland, OH (US);

Inventors:

Babal Kant Jha, Cleveland, OH (US);

James G. Phillips, Cleveland, OH (US);

Jaroslaw P. Maciejewski, Cleveland, OH (US);

Frederic Joel Reu, Cleveland, OH (US);

Assignee:

THE CLEVELAND CLINIC FOUNDATION, Cleveland, OH (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 235/84 (2006.01); A61P 7/00 (2006.01); C07C 235/64 (2006.01); C07C 235/66 (2006.01); C07C 237/40 (2006.01);
U.S. Cl.
CPC ...
C07C 235/84 (2013.01); C07C 235/66 (2013.01);
Abstract

Compounds that can be used to increase NAD levels are described by inhibiting NAD+ degrading enzymes such as CD38 are described. The compounds have a structure according to formula I or Formula II, as described herein, or pharmaceutically acceptable salts thereof, wherein the attached groups are as defined in the specification. Methods of increasing intracellular NAD+ levels in a subject by administering an effective amount of a compound according to formula I or formula II to the subject are also described.


Find Patent Forward Citations

Quick Actions:

Jha, Babal. (2026). Small molecule nicotinamide adenine dinucleotide modulators (U.S. Patent No. 12741933). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12741933

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…